All In Biotech

Drug Trial Radar · NCT03514589

NeSST2: The Development of a Noninvasive Short Synacthen Test

NeSST2: A Multi-stage Clinical Study to Develop a Non-invasive Short Synacthen Test (SST)

Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 182 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

182

Actual

Start

Oct 12, 2012

Primary completion

Sep 30, 2026

Study completion Dec 31, 2026

Sponsor

Lead sponsor
Sheffield Children's NHS Foundation TrustAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
May 2, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Single group
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, up to 17 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Recently there has been concern about the effect of inhaled steroids, routinely used in the treatment of asthma, on the body's ability to produce its natural stress hormone cortisol. Failure of adequate cortisol production in times of stress e.g. illness, can result in serious illness or death. Patients receiving longterm steroid treatment may have reduced levels of cortisol and not be able to produce adequate amounts in times of need, a process called adrenal suppression. Initially it was thought that the absorption of inhaled steroids into the bloodstream would be too low to cause adrenal suppression however high profile deaths followed by a national survey revealed a number of fatal or near fatal cases of adrenal suppression. The vast majority of these were in children. Since then doctors have been encouraged to ensure that children on high doses of inhaled steroids carry a steroid alert card and that the ability of their adrenal glands to produce adequate amounts of cortisol is checked. However it is unknown what dose of inhaled steroids puts one at risk, whether age or gender affects one's risk and when to check the function of the adrenal gland. The Short Synacthen Test (SST) investigates the ability of the body's adrenal glands to produce cortisol. Presently the SST requires intravenous (i.v) cannulation through which Synacthen is injected to stimulate the adrenal glands and multiple blood samples are collected to assess the response in terms of cortisol production. It is invasive, time consuming and unpleasant for the child. Our project aims to produce a noninvasive alternative to the current SST, with Synacthen given nasally and using saliva to measure the subsequent production of cortisol. A noninvasive test will allow us to establish the first normal ranges for children and determine which children with asthma are at risk of adrenal suppression.

Conditions

  • Adrenal Suppression

Interventions

  • nasal TetracosactideDrug

    Bioavailability of nasal synacthen compared to IV comparator

  • IV tetracosactideDrug

    Bioavailability of nasal synacthen compared to IV comparator

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Peak plasma cortisol concentration (Cmax)Time frame: 6 months
  2. Time of peak plasma cortisol concentration (Tmax)Time frame: 6 months
  3. Bioavailability of nasal Synacthen (compared to IV Synacthen)Time frame: 6 months
  4. Area under the curve for plasma Synacthen (nasal compared to IV)Time frame: 6 months
  5. Area under the curve for plasma cortisol (nasal compared to IV)Time frame: 6 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Sheffield Children's NHS Foundation Trust

    Sheffield, Sheffield (South Yorkshire District), United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.